| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.22 | 0.05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |